Chemical probes and drug leads from advances in synthetic planning and methodology
Strategies such as diversity-oriented synthesis aim to explore novel areas of chemical space efficiently by populating small-molecule screening libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. This article h...
Saved in:
Published in | Nature reviews. Drug discovery Vol. 17; no. 5; pp. 333 - 352 |
---|---|
Main Authors | , |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.05.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
ISSN | 1474-1776 1474-1784 1474-1784 |
DOI | 10.1038/nrd.2018.53 |
Cover
Abstract | Strategies such as diversity-oriented synthesis aim to explore novel areas of chemical space efficiently by populating small-molecule screening libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. This article highlights how the design and synthesis of such libraries have been enabled by modern synthetic chemistry and illustrates the impact of the resultant chemical probes and drug leads in a wide range of diseases.
Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for drug discovery. In this article, we focus on strategies such as diversity-oriented synthesis that aim to explore novel areas of chemical space efficiently by populating small-molecule libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. Drawing from more than a decade's worth of examples, we highlight how the design and synthesis of such libraries have been enabled by modern synthetic chemistry, and we illustrate the impact of the resultant chemical probes and drug leads in a wide range of diseases. |
---|---|
AbstractList | Screening of small-molecule libraries is a productive method for
identifying both chemical probes of disease-related targets and potential
starting points for drug discovery. In this article, we focus on strategies such
as diversity-oriented synthesis that aim to explore novel areas of chemical
space efficiently by populating small-molecule libraries with compounds
containing structural features that are typically under-represented in
commercially available screening collections. Drawing from over a
decade’s worth of examples, we highlight how the design and synthesis of
such libraries have been enabled by modern synthetic chemistry, and we
illustrate the impact of the resultant chemical probes and drug leads in a wide
range of diseases. Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for drug discovery. In this article, we focus on strategies such as diversity-oriented synthesis that aim to explore novel areas of chemical space efficiently by populating small-molecule libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. Drawing from more than a decade's worth of examples, we highlight how the design and synthesis of such libraries have been enabled by modern synthetic chemistry, and we illustrate the impact of the resultant chemical probes and drug leads in a wide range of diseases. Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for drug discovery. In this article, we focus on strategies such as diversity-oriented synthesis that aim to explore novel areas of chemical space efficiently by populating small-molecule libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. Drawing from more than a decade's worth of examples, we highlight how the design and synthesis of such libraries have been enabled by modern synthetic chemistry, and we illustrate the impact of the resultant chemical probes and drug leads in a wide range of diseases.Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for drug discovery. In this article, we focus on strategies such as diversity-oriented synthesis that aim to explore novel areas of chemical space efficiently by populating small-molecule libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. Drawing from more than a decade's worth of examples, we highlight how the design and synthesis of such libraries have been enabled by modern synthetic chemistry, and we illustrate the impact of the resultant chemical probes and drug leads in a wide range of diseases. Strategies such as diversity-oriented synthesis aim to explore novel areas of chemical space efficiently by populating small-molecule screening libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. This article highlights how the design and synthesis of such libraries have been enabled by modern synthetic chemistry and illustrates the impact of the resultant chemical probes and drug leads in a wide range of diseases.Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for drug discovery. In this article, we focus on strategies such as diversity-oriented synthesis that aim to explore novel areas of chemical space efficiently by populating small-molecule libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. Drawing from more than a decade's worth of examples, we highlight how the design and synthesis of such libraries have been enabled by modern synthetic chemistry, and we illustrate the impact of the resultant chemical probes and drug leads in a wide range of diseases. Strategies such as diversity-oriented synthesis aim to explore novel areas of chemical space efficiently by populating small-molecule screening libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. This article highlights how the design and synthesis of such libraries have been enabled by modern synthetic chemistry and illustrates the impact of the resultant chemical probes and drug leads in a wide range of diseases. Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for drug discovery. In this article, we focus on strategies such as diversity-oriented synthesis that aim to explore novel areas of chemical space efficiently by populating small-molecule libraries with compounds containing structural features that are typically under-represented in commercially available screening collections. Drawing from more than a decade's worth of examples, we highlight how the design and synthesis of such libraries have been enabled by modern synthetic chemistry, and we illustrate the impact of the resultant chemical probes and drug leads in a wide range of diseases. |
Author | Gerry, Christopher J. Schreiber, Stuart L. |
AuthorAffiliation | 2 The Broad Institute of Harvard & MIT, 415 Main Street, Cambridge, Massachusetts 02142, USA 1 Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA 3 Howard Hughes Medical Institute, Cambridge, Massachusetts 02138, USA |
AuthorAffiliation_xml | – name: 2 The Broad Institute of Harvard & MIT, 415 Main Street, Cambridge, Massachusetts 02142, USA – name: 1 Department of Chemistry and Chemical Biology, Harvard University, 12 Oxford Street, Cambridge, Massachusetts 02138, USA – name: 3 Howard Hughes Medical Institute, Cambridge, Massachusetts 02138, USA |
Author_xml | – sequence: 1 givenname: Christopher J. surname: Gerry fullname: Gerry, Christopher J. organization: Department of Chemistry and Chemical Biology, Harvard University, The Broad Institute of Harvard & MIT – sequence: 2 givenname: Stuart L. surname: Schreiber fullname: Schreiber, Stuart L. email: schreiber@broadinstitute.org organization: Department of Chemistry and Chemical Biology, Harvard University, The Broad Institute of Harvard & MIT, Howard Hughes Medical Institute |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29651105$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kc1r3DAQxUVJaJJtT70XQy6FZrcjyZLsS6AszQcEAqE9C1mSvQq2tJHswP731XbTbROaooOE5jdv5vFO0IEP3iL0AcMCA62--GgWBHC1YPQNOsalKOdYVOXB_i34ETpJ6R4AcyzIW3REas4wBnaM7pYrOzit-mIdQ2NTobwpTJy6orfKpKKNYSiUeVRe56LzRdr4cWVHp4t1r7x3vvvVMthxFUzoQ7d5hw5b1Sf7_umeoR8X374vr-Y3t5fXy683c82AjnPeWE1pQ2oAbURLDMGccwI1rVhlMBOitlQzzsqmbUWbP8HqVhsQqmqoEnSGzne666kZrNHWj1H1ch3doOJGBuXk84p3K9mFR8kF5IOzwKcngRgeJptGObikbZ992TAlSYAwikkt6oyevkDvwxR9ticpLinUhFf0fxSBEkRJaE5shj7-vfd-4d-hZODzDtAxpBRtu0cwyG3kMkcut5FLth2KX9DajWp0YWva9a_0nO16Ulb2nY1_Fv0X_hM7Abz1 |
CitedBy_id | crossref_primary_10_1097_MD_0000000000034439 crossref_primary_10_33483_jfpau_681611 crossref_primary_10_3390_app12168262 crossref_primary_10_3390_md20070438 crossref_primary_10_1073_pnas_2114324119 crossref_primary_10_1021_jacs_9b13186 crossref_primary_10_1021_acscatal_2c05283 crossref_primary_10_1002_anie_202316458 crossref_primary_10_1002_ejoc_202000619 crossref_primary_10_1016_j_chembiol_2024_05_004 crossref_primary_10_1002_ange_201907366 crossref_primary_10_1021_acs_joc_0c02059 crossref_primary_10_1021_acs_orglett_8b01602 crossref_primary_10_1039_D2CC01677J crossref_primary_10_1038_nrd_2018_116 crossref_primary_10_1016_j_crgsc_2021_100170 crossref_primary_10_1038_s41467_020_20478_5 crossref_primary_10_3390_molecules27134169 crossref_primary_10_1126_science_adk5864 crossref_primary_10_1038_s41565_021_00872_w crossref_primary_10_1016_j_molcel_2023_04_028 crossref_primary_10_1016_j_cjche_2020_05_035 crossref_primary_10_1016_j_carbpol_2019_115163 crossref_primary_10_3389_fphar_2022_837715 crossref_primary_10_1002_cplu_202300537 crossref_primary_10_1016_j_bmc_2021_116218 crossref_primary_10_1039_D2MD00291D crossref_primary_10_1007_s00018_021_03983_8 crossref_primary_10_1002_ejoc_202101440 crossref_primary_10_1039_D0NJ05697A crossref_primary_10_1039_D3RA06831E crossref_primary_10_3389_fchem_2018_00507 crossref_primary_10_33483_jfpau_620599 crossref_primary_10_1002_adsc_202000755 crossref_primary_10_1039_D4SC01515K crossref_primary_10_2174_1389201023666220921091240 crossref_primary_10_1016_j_drudis_2024_104237 crossref_primary_10_3389_fphar_2022_929836 crossref_primary_10_1002_ange_202005432 crossref_primary_10_1021_acs_joc_1c00774 crossref_primary_10_1038_s41573_021_00210_8 crossref_primary_10_1021_acs_joc_9b00148 crossref_primary_10_1038_s41467_022_28108_y crossref_primary_10_1016_j_cbpa_2018_12_007 crossref_primary_10_1049_iet_syb_2018_5037 crossref_primary_10_1016_j_xinn_2025_100809 crossref_primary_10_1016_j_cbpa_2022_102186 crossref_primary_10_2139_ssrn_3936778 crossref_primary_10_1002_cmdc_201900054 crossref_primary_10_1007_s00044_020_02571_y crossref_primary_10_1016_j_bioorg_2023_106698 crossref_primary_10_1126_science_aat0805 crossref_primary_10_1021_acschembio_2c00052 crossref_primary_10_1002_cbic_201800768 crossref_primary_10_1002_ijch_201800113 crossref_primary_10_1002_ejoc_201800962 crossref_primary_10_1039_D2GC02461F crossref_primary_10_1021_acsmedchemlett_1c00340 crossref_primary_10_1002_cbic_201800751 crossref_primary_10_1016_j_chembiol_2024_10_005 crossref_primary_10_1039_D0CC06975B crossref_primary_10_1039_D3CC02086J crossref_primary_10_1039_D2SC03016K crossref_primary_10_1016_j_tet_2018_07_028 crossref_primary_10_3389_fphar_2023_1244317 crossref_primary_10_1039_D4MD00770K crossref_primary_10_1016_j_biopha_2022_113759 crossref_primary_10_3389_fchem_2018_00522 crossref_primary_10_1039_D2RA06726A crossref_primary_10_3389_fchem_2020_580355 crossref_primary_10_1016_j_cbpa_2019_08_008 crossref_primary_10_1080_17460441_2019_1654453 crossref_primary_10_1016_j_tgchem_2025_100065 crossref_primary_10_3389_fchem_2022_997944 crossref_primary_10_1016_j_bmc_2020_115834 crossref_primary_10_1186_s13062_020_00274_3 crossref_primary_10_3390_ijms21144988 crossref_primary_10_1039_C9NP00068B crossref_primary_10_1093_nar_gkac909 crossref_primary_10_1002_cbic_202400762 crossref_primary_10_3389_fonc_2021_654428 crossref_primary_10_1002_anie_202205515 crossref_primary_10_1177_2472555218812657 crossref_primary_10_1002_cmdc_201800537 crossref_primary_10_1016_j_drudis_2020_09_027 crossref_primary_10_1039_D2CB00223J crossref_primary_10_1021_acs_accounts_0c00466 crossref_primary_10_1038_s41573_019_0049_9 crossref_primary_10_1038_s41597_023_02513_4 crossref_primary_10_1021_jacs_9b01203 crossref_primary_10_55544_jrasb_3_2_16 crossref_primary_10_1271_kagakutoseibutsu_59_45 crossref_primary_10_1021_acsomega_2c06585 crossref_primary_10_1021_jacs_8b07319 crossref_primary_10_1016_j_crchbi_2022_100028 crossref_primary_10_1002_open_202000017 crossref_primary_10_1021_jacsau_4c00042 crossref_primary_10_3390_biom13071081 crossref_primary_10_1021_acs_oprd_1c00225 crossref_primary_10_1073_pnas_2313210120 crossref_primary_10_1016_j_bmcl_2022_128732 crossref_primary_10_3390_pharmaceutics17040404 crossref_primary_10_1126_scitranslmed_aba8412 crossref_primary_10_3390_molecules29071562 crossref_primary_10_1002_asia_202001105 crossref_primary_10_1021_acs_joc_3c00513 crossref_primary_10_1039_D4RA02523G crossref_primary_10_1038_s41570_020_0201_4 crossref_primary_10_1246_cl_210241 crossref_primary_10_1002_slct_201802310 crossref_primary_10_33483_jfpau_533166 crossref_primary_10_1021_acs_joc_3c01169 crossref_primary_10_1021_acs_orglett_8b02562 crossref_primary_10_1038_s41557_020_0513_5 crossref_primary_10_1002_adsc_202001245 crossref_primary_10_1016_j_cbpa_2020_03_003 crossref_primary_10_1016_j_drudis_2019_03_007 crossref_primary_10_1071_CH23029 crossref_primary_10_1002_anie_201912043 crossref_primary_10_1039_D2SC05768A crossref_primary_10_1021_acs_joc_9b02127 crossref_primary_10_1039_D3RA03800A crossref_primary_10_1021_acs_jmedchem_2c00710 crossref_primary_10_1002_slct_202403695 crossref_primary_10_3762_bjoc_18_141 crossref_primary_10_1038_s41467_022_29984_0 crossref_primary_10_1002_ejoc_202200575 crossref_primary_10_1016_j_molstruc_2021_131588 crossref_primary_10_1109_TNB_2020_2977304 crossref_primary_10_1007_s12257_022_0268_5 crossref_primary_10_1002_chem_202000335 crossref_primary_10_1021_jacs_3c10741 crossref_primary_10_1002_slct_201803748 crossref_primary_10_1186_s12936_021_03632_2 crossref_primary_10_3390_molecules24203811 crossref_primary_10_1002_jhet_4285 crossref_primary_10_1021_acs_jmedchem_8b00653 crossref_primary_10_1016_j_cell_2019_04_009 crossref_primary_10_1021_acs_jmedchem_9b00359 crossref_primary_10_1039_C9OB02030F crossref_primary_10_3390_molecules29122861 crossref_primary_10_1002_ird3_47 crossref_primary_10_1016_j_tet_2018_08_015 crossref_primary_10_1021_acschembio_9b00714 crossref_primary_10_3390_molecules27072171 crossref_primary_10_1021_acs_joc_8b01831 crossref_primary_10_1038_s41557_019_0261_6 crossref_primary_10_1039_D4OB00853G crossref_primary_10_1039_D2RA03744K crossref_primary_10_3390_ijms23115936 crossref_primary_10_1002_anie_201907366 crossref_primary_10_1016_j_corsci_2019_108245 crossref_primary_10_1038_s41467_022_34598_7 crossref_primary_10_1002_anie_202005432 crossref_primary_10_1002_ange_201912043 crossref_primary_10_1016_j_xcrp_2022_101097 crossref_primary_10_1021_acschembio_9b00294 crossref_primary_10_1073_pnas_1806900115 crossref_primary_10_1002_ange_202316458 crossref_primary_10_1002_ange_202205515 crossref_primary_10_1016_j_cbpa_2022_102150 crossref_primary_10_1021_acs_jmedchem_2c01491 crossref_primary_10_1016_j_isci_2022_104437 crossref_primary_10_1021_acscombsci_0c00077 crossref_primary_10_1038_s41467_023_40575_5 crossref_primary_10_1021_acs_joc_8b01708 crossref_primary_10_3389_fphar_2020_00422 crossref_primary_10_1002_cbic_202000356 crossref_primary_10_1039_C8OB02327A crossref_primary_10_1007_s10489_023_04915_8 crossref_primary_10_1021_acs_joc_1c01764 crossref_primary_10_2174_1573409918666220804142753 crossref_primary_10_1021_acs_chemrev_9b00214 crossref_primary_10_1038_s42256_021_00410_2 |
Cites_doi | 10.1146/annurev-pharmtox-010715-103440 10.1038/ncb2152 10.1038/nrc3068 10.1128/AAC.01443-07 10.1021/ja0457415 10.1016/j.cell.2011.02.013 10.1016/j.bbagen.2013.02.008 10.1038/nrdp.2016.20 10.1038/nchembio.1858 10.1021/acsmedchemlett.7b00030 10.1038/nrd1657 10.1016/j.gde.2012.12.005 10.1038/nrd.2016.109 10.1126/science.3887571 10.1126/science.1109755 10.1517/14728220902832697 10.1021/jm500994n 10.1371/journal.pone.0080999 10.1002/anie.201302045 10.1002/anie.201310843 10.1016/j.chembiol.2013.03.020 10.1016/j.antiviral.2016.03.015 10.1002/anie.200700762 10.1016/j.chom.2015.12.001 10.1016/j.drudis.2013.02.005 10.1021/ja511232b 10.1126/science.287.5460.1964 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D 10.1038/nchembio0807-442 10.1038/nature02009 10.1038/nrd4737 10.1021/ja0352698 10.1038/nbt.3460 10.1021/ja044798o 10.1016/S0140-6736(15)00151-8 10.1038/nature16549 10.1021/jacs.5b04284 10.1021/co300098v 10.1021/acs.orglett.6b03118 10.1093/emboj/17.11.3052 10.1086/651706 10.1038/ncb2038 10.1158/0008-5472.CAN-13-3130 10.1002/anie.201007004 10.1021/jm400362b 10.1038/nrd4204 10.1038/nature03193 10.1093/infdis/jiu565 10.1111/j.1751-7915.2008.00031.x 10.1158/1078-0432.CCR-07-2184 10.1021/ol8004936 10.1016/j.cell.2015.05.023 10.1073/pnas.1115031108 10.1021/acs.jmedchem.5b01874 10.1002/anie.200802439 10.1021/ja102798t 10.1126/science.1116364 10.1021/acs.jnatprod.5b01055 10.1038/457153a 10.1021/ci000403i 10.1021/ja992658m 10.1093/ndt/gfs442 10.1038/nchembio0705-74 10.1016/j.cbpa.2004.04.017 10.1073/pnas.1012741107 10.1016/j.tetlet.2011.08.071 10.1038/ncomms4155 10.1038/nrd3802 10.3389/fonc.2015.00021 10.1056/NEJM199401273300406 10.1038/nm.3248 10.1038/ncomms6521 10.1021/jacs.6b04614 10.1056/NEJMoa0808859 10.1038/nbt.3419 10.1038/nrm1245 10.1038/nrd1343 10.1039/C4NP00104D 10.1016/j.bmcl.2009.09.089 10.1021/cc9800071 10.1038/nrg1317 10.1371/journal.pmed.0040238 10.1038/nrd4366 10.1126/science.275.5308.1943 10.1007/s00424-013-1234-z 10.1021/ol016915f 10.1038/nrd.2017.111 10.1016/j.oraloncology.2012.11.008 10.1016/j.chembiol.2011.12.014 10.1179/2047773215Y.0000000013 10.1002/1521-3773(20000901)39:17<3012::AID-ANIE3012>3.0.CO;2-G 10.1101/gad.938601 10.1016/j.chom.2012.12.006 10.1056/NEJMoa1315860 10.3389/fonc.2015.00278 10.1021/ml500388q 10.1128/AAC.01144-06 10.1126/science.1238303 10.1038/nrmicro3380 10.1038/nrd3895 10.1111/febs.12077 10.1021/ja992144n 10.1002/anie.200703073 10.1038/nchembio.479 10.1038/383407a0 10.1126/scitranslmed.aaf2608 10.1126/science.1190354 10.1016/j.drudis.2012.10.011 10.1038/nature17967 10.1016/j.cell.2007.07.020 10.1021/acsmedchemlett.6b00230 10.1021/ol005574n 10.1021/ja105119r 10.1021/jacs.7b06994 10.1126/science.1156409 10.1073/pnas.1015251108 10.1016/S1367-5931(97)80107-X 10.1038/nchembio.758 10.1073/pnas.0430973100 10.1016/j.chembiol.2014.11.012 10.1016/S0140-6736(12)62129-1 10.1007/s10822-011-9444-y 10.1016/j.addr.2015.01.009 10.1016/j.cbpa.2010.03.022 10.1038/nchembio.2420 10.1021/acsmedchemlett.6b00264 10.1074/jbc.M112.345702 10.1038/clpt.2012.236 10.1016/j.chembiol.2006.03.004 10.3390/molecules200713384 10.1038/nchembio.296 10.1186/s13059-014-0544-6 10.1016/j.cbpa.2004.04.003 10.1038/nrmicro3138 10.1126/scitranslmed.aaa7161 10.1152/japplphysiol.01143.2001 10.1038/nrd4683 10.1126/science.287.5460.1960 10.1073/pnas.1015024108 10.1021/jm201263k 10.2174/1568026614666140929124445 10.1021/acscombsci.6b00050 10.1038/nchembio.1867 10.1038/nature19804 10.1038/nmeth.4365 10.1002/anie.200600497 10.1073/pnas.141230798 10.1021/cb300151m 10.1038/onc.2010.277 10.1038/nchembio.1197 10.1021/jm400397x 10.1158/1535-7163.MCT-09-0765 10.1021/jm020017n 10.1021/acs.accounts.6b00185 10.1056/NEJMp1215093 10.1073/pnas.1015268108 10.1038/nrc2559 10.1038/onc.2009.4 10.1038/nchembio.2115 10.1128/MMBR.00016-10 10.1038/nm1003 10.1002/anie.200804486 10.1038/nature19057 10.1073/pnas.1015254108 10.1124/pr.112.007336 10.1002/anie.201605460 10.1128/AAC.06377-11 10.1038/ng1196-357 10.1038/ng.733 10.1021/cb500616x 10.1021/ar500432k 10.1038/nature03095 10.1016/S1074-5521(03)00095-4 10.1016/S1470-2045(15)70051-3 10.1016/j.cell.2008.02.041 10.1371/journal.pntd.0004094 10.1038/ng1362 10.1126/science.1176667 10.1158/0008-5472.CAN-13-1994 10.1038/nature12828 10.1038/nchem.730 10.1073/pnas.0503221102 10.1016/S0169-409X(96)00423-1 10.1016/j.cell.2017.10.049 10.1126/science.257.5073.1050 10.1101/cshperspect.a000414 10.1016/j.chembiol.2010.05.013 10.1021/acsinfecdis.6b00206 10.1021/ja300799t 10.1038/nrc3599 10.1038/513481a 10.1371/journal.pone.0120295 10.1002/anie.200300626 10.1038/nature14451 10.1038/nchembio.911 10.1002/anie.200503132 10.1016/j.cbpa.2008.03.016 10.1021/ja400034k 10.1038/nrd.2017.226 10.1021/jacs.7b06087 10.1038/nrd4051 10.1038/nchembio.1130 10.1038/nchembio.2207 10.1021/ml200244k 10.1016/j.drudis.2013.07.001 10.1021/jm3001373 10.1038/ncomms13196 10.1158/1078-0432.CCR-14-0507 10.1038/nrd4389 10.1016/j.antiviral.2009.10.003 10.1021/ml200120m 10.2533/000942903777679253 10.1021/co200161z 10.1021/ml400403u 10.1073/pnas.1410933111 10.1038/nrc1736 10.1002/anie.200390233 10.1126/science.1065817 10.1038/nrd3975 10.1172/JCI21682 10.1021/ol047945w 10.1073/pnas.1015248108 10.1016/j.cbpa.2010.03.018 10.1021/ja00034a086 10.1039/C5NP00127G 10.1038/cr.2013.168 10.1021/jo300974j 10.1021/acschembio.5b00981 10.1021/jm049740z 10.1126/science.1193225 10.1038/nrd2201 10.1021/acs.chemrev.5b00760 10.1073/pnas.1103205108 10.1002/anie.201501394 10.1056/NEJMoa013552 10.1038/nchembio.142 10.1016/S0166-6851(96)02593-5 10.1016/j.bmcl.2015.03.073 10.1007/s00281-015-0522-4 10.1016/j.bmcl.2011.01.134 10.1021/jacs.5b02150 10.1002/anie.200705415 10.1016/j.abb.2012.01.016 10.1021/ja062621j 10.1039/C4MD00237G 10.1016/j.chembiol.2015.11.011 10.1126/science.aab1433 10.1039/B910196A 10.1016/j.cell.2013.03.034 10.1016/S0140-6736(03)15162-8 10.1016/j.chembiol.2017.11.004 10.1016/j.ccell.2017.06.005 10.1002/anie.201003212 10.1002/anie.201505717 |
ContentType | Journal Article |
Copyright | Springer Nature Limited 2018 Copyright Nature Publishing Group May 2018 |
Copyright_xml | – notice: Springer Nature Limited 2018 – notice: Copyright Nature Publishing Group May 2018 |
DBID | AAYXX CITATION NPM 3V. 7RV 7X7 7XB 88E 8AO 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/nrd.2018.53 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | PubMed MEDLINE - Academic ProQuest One Academic Middle East (New) ProQuest One Academic Middle East (New) |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1474-1784 |
EndPage | 352 |
ExternalDocumentID | PMC6707071 29651105 10_1038_nrd_2018_53 |
Genre | Review Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIGMS NIH HHS grantid: R01 GM038627 |
GroupedDBID | --- 0R~ 123 29M 36B 39C 3V. 4.4 53G 70F 7RV 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AAEEF AARCD AAWYQ AAYOK AAYZH AAZLF ABAWZ ABDBF ABJNI ABLJU ABNNU ABUWG ACGFO ACGFS ACMJI ACRPL ACUHS ADBBV ADFRT ADNMO AENEX AFBBN AFKRA AFSHS AGAYW AGGDT AGHTU AHBCP AHMBA AHOSX AHSBF AIBTJ AIYXT ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMTXH ARMCB ASPBG AVWKF AXYYD AZFZN B0M BENPR BKEYQ BKKNO BPHCQ BVXVI CCPQU CS3 DB5 DU5 EAD EAP EBS EE. EJD EMB EMK EMOBN EPL ESX EX3 EXGXG F5P FEDTE FQGFK FSGXE FYUFA HMCUK HVGLF HZ~ IAO IHR INH INR ITC L-9 LGEZI LOTEE M1P MK0 N9A NADUK NAPCQ NNMJJ NXXTH O9- ODYON P2P PQQKQ PROAC PSQYO Q2X RNR RNS RNT RNTTT SHXYY SIXXV SNYQT SOJ SV3 TAOOD TBHMF TDRGL TSG TUS UKHRP WOW ~8M AAYXX ACMFV AFANA ALPWD ATHPR CITATION PHGZM PHGZT ABFSG ACSTC AEZWR AFHIU AGQPQ AHWEU AIXLP NFIDA NPM PJZUB PPXIY 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 PUEGO 5PM |
ID | FETCH-LOGICAL-c503t-6bec33b2900cd7f2d216662093858d15779e3c5654bff7f8580ecfcd07a8b3a73 |
IEDL.DBID | 7X7 |
ISSN | 1474-1776 1474-1784 |
IngestDate | Thu Aug 21 18:27:12 EDT 2025 Fri Sep 05 10:09:00 EDT 2025 Sat Aug 23 12:49:05 EDT 2025 Fri Jul 25 08:58:25 EDT 2025 Mon Jul 21 06:08:06 EDT 2025 Thu Apr 24 22:57:27 EDT 2025 Tue Jul 01 02:15:04 EDT 2025 Fri Feb 21 02:36:23 EST 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c503t-6bec33b2900cd7f2d216662093858d15779e3c5654bff7f8580ecfcd07a8b3a73 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Review-3 content type line 23 |
PMID | 29651105 |
PQID | 2040742310 |
PQPubID | 27580 |
PageCount | 20 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6707071 proquest_miscellaneous_2025312979 proquest_journals_3143092683 proquest_journals_2040742310 pubmed_primary_29651105 crossref_primary_10_1038_nrd_2018_53 crossref_citationtrail_10_1038_nrd_2018_53 springer_journals_10_1038_nrd_2018_53 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2018-05-01 |
PublicationDateYYYYMMDD | 2018-05-01 |
PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | Nature reviews. Drug discovery |
PublicationTitleAbbrev | Nat Rev Drug Discov |
PublicationTitleAlternate | Nat Rev Drug Discov |
PublicationYear | 2018 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | JS Lazo (BFnrd201853_CR154) 2016; 56 LA Marcaurelle (BFnrd201853_CR94) 2010; 132 N Moitessier (BFnrd201853_CR11) 2016; 49 DH-C Chou (BFnrd201853_CR73) 2011; 2 M Lek (BFnrd201853_CR55) 2016; 536 MD Kärkäs (BFnrd201853_CR145) 2016; 116 B Gerard (BFnrd201853_CR141) 2004; 126 S Dandapani (BFnrd201853_CR16) 2010; 6 DJ Newman (BFnrd201853_CR9) 2016; 79 M Bredel (BFnrd201853_CR110) 2004; 5 I Paterson (BFnrd201853_CR52) 2005; 310 V Bavetsias (BFnrd201853_CR131) 2015; 5 DC Swinney (BFnrd201853_CR67) 2013; 93 FE Koehn (BFnrd201853_CR5) 2005; 4 S Wetzel (BFnrd201853_CR34) 2011; 50 AE Owens (BFnrd201853_CR89) 2017; 139 LG Ferreira (BFnrd201853_CR10) 2015; 20 JMA Blair (BFnrd201853_CR4) 2015; 13 T Hideshima (BFnrd201853_CR45) 2005; 102 Y Younis (BFnrd201853_CR208) 2012; 55 C Dai (BFnrd201853_CR137) 2007; 130 BG Wilson (BFnrd201853_CR146) 2011; 11 SW Fesik (BFnrd201853_CR106) 2005; 5 H Oguri (BFnrd201853_CR40) 2005; 7 WY Siau (BFnrd201853_CR32) 2014; 136 J Chu (BFnrd201853_CR167) 2016; 12 T Kogej (BFnrd201853_CR229) 2013; 18 F Kopp (BFnrd201853_CR27) 2012; 8 S Wellington (BFnrd201853_CR179) 2017; 13 C Hansch (BFnrd201853_CR245) 2011; 25 N Kato (BFnrd201853_CR178) 2016; 538 B Baragaña (BFnrd201853_CR209) 2015; 522 DM Huryn (BFnrd201853_CR124) 2011; 108 C Dockendorff (BFnrd201853_CR79) 2015; 25 GE Winter (BFnrd201853_CR232) 2015; 348 SA Dugger (BFnrd201853_CR57) 2017; 17 PM Wright (BFnrd201853_CR173) 2014; 53 AB Vaidya (BFnrd201853_CR199) 2014; 5 A Sekar (BFnrd201853_CR63) 2016; 530 AN Koehler (BFnrd201853_CR140) 2010; 14 JC Van Pelt-Koops (BFnrd201853_CR197) 2012; 56 TKH Scheel (BFnrd201853_CR170) 2013; 19 LA Sonna (BFnrd201853_CR135) 2002; 92 BZ Stanton (BFnrd201853_CR87) 2010; 6 LF Peng (BFnrd201853_CR90) 2009; 19 JM Law (BFnrd201853_CR117) 2016; 7 M Carmena (BFnrd201853_CR128) 2003; 4 TD Aicher (BFnrd201853_CR50) 1992; 114 SJ Little (BFnrd201853_CR161) 2002; 347 GL Verdine (BFnrd201853_CR113) 2007; 13 DC Rubinsztein (BFnrd201853_CR97) 2012; 11 JR Duvall (BFnrd201853_CR183) 2016; 131 DF Veber (BFnrd201853_CR249) 2002; 45 G Moura-Letts (BFnrd201853_CR30) 2011; 108 JR Bischoff (BFnrd201853_CR129) 1998; 17 Y Wang (BFnrd201853_CR71) 2016; 7 F Martins (BFnrd201853_CR100) 2013; 49 AK Lukens (BFnrd201853_CR174) 2015; 211 RM Plenge (BFnrd201853_CR58) 2013; 12 J Kim (BFnrd201853_CR80) 2016; 7 B Meyer (BFnrd201853_CR234) 2003; 42 NJ White (BFnrd201853_CR190) 2004; 113 A Subramanian (BFnrd201853_CR239) 2017; 171 K Dheda (BFnrd201853_CR217) 2016; 387 LA Salvador-Reyes (BFnrd201853_CR21) 2015; 32 BFnrd201853_CR189 SM Sternson (BFnrd201853_CR42) 2001; 3 BZ Stanton (BFnrd201853_CR77) 2009; 5 IB Seiple (BFnrd201853_CR54) 2016; 533 EL Flannery (BFnrd201853_CR187) 2013; 11 PW Ingham (BFnrd201853_CR84) 2001; 15 SJ Haggarty (BFnrd201853_CR44) 2003; 100 JE Bradner (BFnrd201853_CR88) 2006; 13 BM Ibbeson (BFnrd201853_CR115) 2014; 5 MF Dunn (BFnrd201853_CR219) 2012; 519 A Chaikuad (BFnrd201853_CR150) 2014; 5 S Dandapani (BFnrd201853_CR49) 2010; 14 WH Gerwick (BFnrd201853_CR6) 2012; 19 BFnrd201853_CR59 S-Y Kuo (BFnrd201853_CR78) 2015; 112 SP Thayer (BFnrd201853_CR85) 2003; 425 MS Taylor (BFnrd201853_CR24) 2006; 45 ML Baniecki (BFnrd201853_CR186) 2007; 51 S Tian (BFnrd201853_CR250) 2015; 86 AP Antonchick (BFnrd201853_CR29) 2010; 2 EA Winzeler (BFnrd201853_CR191) 2014; 15 J Baell (BFnrd201853_CR248) 2014; 513 PI Dalko (BFnrd201853_CR23) 2001; 40 D Batlle (BFnrd201853_CR261) 2012; 27 N Kumagai (BFnrd201853_CR41) 2006; 45 J Davies (BFnrd201853_CR165) 2010; 74 A Nuhs (BFnrd201853_CR184) 2015; 9 Y Xing (BFnrd201853_CR157) 2008; 133 DM Plouffe (BFnrd201853_CR176) 2016; 19 MJ Wawer (BFnrd201853_CR225) 2014; 111 MJ Towle (BFnrd201853_CR51) 2001; 61 IH Gilbert (BFnrd201853_CR69) 2013; 56 JF Blake (BFnrd201853_CR251) 2004; 8 S Haftchenary (BFnrd201853_CR252) 2016; 18 S Jones (BFnrd201853_CR111) 2015; 7 J Blagg (BFnrd201853_CR257) 2017; 32 KM Sakamoto (BFnrd201853_CR231) 2001; 98 SW Park (BFnrd201853_CR180) 2015; 22 M Dyer (BFnrd201853_CR194) 1996; 78 AK Ghose (BFnrd201853_CR253) 1999; 1 K Lewis (BFnrd201853_CR164) 2013; 12 DA Bachovchin (BFnrd201853_CR120) 2011; 108 RM Franzini (BFnrd201853_CR237) 2016; 59 MR Spaller (BFnrd201853_CR15) 1997; 1 DS Tan (BFnrd201853_CR38) 1999; 121 B Gerard (BFnrd201853_CR143) 2006; 128 JT Lowe (BFnrd201853_CR206) 2012; 77 DJ Payne (BFnrd201853_CR168) 2007; 6 D Cruz (BFnrd201853_CR76) 2011; 108 SL Schreiber (BFnrd201853_CR66) 2015; 161 MM Nagiec (BFnrd201853_CR81) 2015; 10 SL Schreiber (BFnrd201853_CR33) 2000; 287 RA Bauer (BFnrd201853_CR26) 2012; 9 AD Cox (BFnrd201853_CR112) 2014; 13 A Bhargava (BFnrd201853_CR262) 2012; 287 AA Dar (BFnrd201853_CR133) 2010; 9 CM Rodrigo (BFnrd201853_CR144) 2012; 55 ME Fitzgerald (BFnrd201853_CR101) 2012; 14 T Terai (BFnrd201853_CR230) 2013; 465 C Holohan (BFnrd201853_CR2) 2013; 13 WK Smits (BFnrd201853_CR213) 2016; 2 DA Erlanson (BFnrd201853_CR12) 2016; 15 PY Ng (BFnrd201853_CR121) 2007; 46 M Maetani (BFnrd201853_CR175) 2017; 8 A Fürstner (BFnrd201853_CR25) 2000; 39 H Salamon (BFnrd201853_CR236) 2016; 11 SV Frye (BFnrd201853_CR255) 2015; 14 S Saha (BFnrd201853_CR151) 2001; 294 S Santagata (BFnrd201853_CR136) 2011; 108 SL Schreiber (BFnrd201853_CR48) 2011; 108 AM Zuhl (BFnrd201853_CR160) 2012; 134 MB Jiménez-Díaz (BFnrd201853_CR200) 2014; 111 AA Shelat (BFnrd201853_CR18) 2007; 3 C Sawyers (BFnrd201853_CR109) 2004; 432 ML Cohen (BFnrd201853_CR162) 1992; 257 E Comer (BFnrd201853_CR205) 2014; 57 JG Moffat (BFnrd201853_CR68) 2017; 16 CA Lipinski (BFnrd201853_CR171) 1997; 23 P Workman (BFnrd201853_CR256) 2010; 17 LN Aldrich (BFnrd201853_CR75) 2015; 137 A Khanna (BFnrd201853_CR155) 2013; 73 V Justilien (BFnrd201853_CR91) 2015; 21 AN Koehler (BFnrd201853_CR123) 2003; 125 SA Stanley (BFnrd201853_CR222) 2012; 7 B Spellberg (BFnrd201853_CR3) 2013; 368 C Fang (BFnrd201853_CR125) 2014; 5 F Nie (BFnrd201853_CR28) 2016; 55 S Dandapani (BFnrd201853_CR181) 2014; 5 RM Plenge (BFnrd201853_CR1) 2016; 8 MD Burke (BFnrd201853_CR103) 2004; 126 GI Schaefer (BFnrd201853_CR72) 2013; 135 W Zheng (BFnrd201853_CR70) 2013; 18 H Zheng (BFnrd201853_CR203) 2015; 54 AMJ Wensing (BFnrd201853_CR169) 2010; 85 JL Reymond (BFnrd201853_CR17) 2015; 48 DP Bondeson (BFnrd201853_CR233) 2015; 11 SP Roche (BFnrd201853_CR142) 2010; 49 R Nussinov (BFnrd201853_CR220) 2013; 153 E Lionta (BFnrd201853_CR13) 2014; 14 J Zhang (BFnrd201853_CR134) 2009; 9 DA Fruman (BFnrd201853_CR108) 2014; 13 MD Burke (BFnrd201853_CR36) 2004; 43 DHC Chou (BFnrd201853_CR92) 2015; 137 M Rottmann (BFnrd201853_CR177) 2010; 329 J Kim (BFnrd201853_CR98) 2011; 13 RM Garbaccio (BFnrd201853_CR254) 2016; 23 NJ Spillman (BFnrd201853_CR195) 2013; 13 SS Scully (BFnrd201853_CR93) 2013; 56 J Kang (BFnrd201853_CR241) 2016; 34 C Lipinski (BFnrd201853_CR247) 2004; 432 M Ciccone (BFnrd201853_CR156) 2015; 5 JR Duvall (BFnrd201853_CR185) 2017; 3 JG Moffat (BFnrd201853_CR105) 2014; 13 K Katsuno (BFnrd201853_CR163) 2015; 14 EL Flannery (BFnrd201853_CR198) 2015; 10 MM Hann (BFnrd201853_CR228) 2004; 8 PY Dakas (BFnrd201853_CR82) 2013; 52 GL Thomas (BFnrd201853_CR182) 2008; 47 TJ Louie (BFnrd201853_CR212) 2009; 53 MS Lajiness (BFnrd201853_CR244) 2004; 47 MG Charest (BFnrd201853_CR53) 2005; 308 J Drost (BFnrd201853_CR148) 2010; 12 M Maetani (BFnrd201853_CR207) 2017; 139 C Lipinski (BFnrd201853_CR246) 2012; 11 PA Clemons (BFnrd201853_CR19) 2010; 107 B Melichar (BFnrd201853_CR132) 2015; 16 ME Bunnage (BFnrd201853_CR64) 2013; 9 AM Dondorp (BFnrd201853_CR193) 2009; 361 D Altshuler (BFnrd201853_CR56) 2008; 322 S Santagata (BFnrd201853_CR116) 2013; 341 T Hidvegi (BFnrd201853_CR96) 2010; 329 H Dückert (BFnrd201853_CR118) 2011; 8 CP Kelly (BFnrd201853_CR211) 1994; 330 Y Momozawa (BFnrd201853_CR60) 2011; 43 AH Meijer (BFnrd201853_CR221) 2016; 38 BL Gray (BFnrd201853_CR74) 2008; 10 BFnrd201853_CR62 BFnrd201853_CR61 C Yan (BFnrd201853_CR114) 2013; 1835 D Lee (BFnrd201853_CR37) 2000; 2 B Campo (BFnrd201853_CR188) 2015; 109 J Li (BFnrd201853_CR152) 1997; 275 MR Arkin (BFnrd201853_CR235) 2004; 3 MA Farha (BFnrd201853_CR166) 2016; 33 TE Nielsen (BFnrd201853_CR35) 2008; 47 B Gerard (BFnrd201853_CR215) 2012; 14 SD Nelson Jr. (BFnrd201853_CR243) 2016; 18 CH Arrowsmith (BFnrd201853_CR65) 2015; 11 NJ White (BFnrd201853_CR196) 2014; 371 SA Munro (BFnrd201853_CR218) 2007; 4 C Yu (BFnrd201853_CR119) 2016; 34 D Reisman (BFnrd201853_CR147) 2009; 28 BFnrd201853_CR216 B Ravikumar (BFnrd201853_CR99) 2004; 36 GM Cragg (BFnrd201853_CR7) 2013; 1830 WHB Sauer (BFnrd201853_CR104) 2003; 57 W Tang (BFnrd201853_CR122) 2011; 21 E Roessler (BFnrd201853_CR86) 1996; 14 WRJD Galloway (BFnrd201853_CR102) 2010; 1 C Chiang (BFnrd201853_CR83) 1996; 383 AF Hohmann (BFnrd201853_CR149) 2016; 12 AA Antolin (BFnrd201853_CR259) 2017; 25 SM Frumm (BFnrd201853_CR127) 2013; 20 A Ganesan (BFnrd201853_CR8) 2008; 12 MM Hann (BFnrd201853_CR227) 2001; 41 L Meng (BFnrd201853_CR138) 2010; 29 PGK Clark (BFnrd201853_CR126) 2015; 54 JM Berlin (BFnrd201853_CR159) 2008; 47 BFnrd201853_CR201 SV Frye (BFnrd201853_CR224) 2010; 6 C Skuta (BFnrd201853_CR258) 2017; 14 SL Schreiber (BFnrd201853_CR47) 2009; 457 PA Clemons (BFnrd201853_CR20) 2011; 108 V Danc̆ík (BFnrd201853_CR22) 2010; 132 D Morton (BFnrd201853_CR31) 2009; 48 SL Fisher (BFnrd201853_CR214) 2008; 1 D Hanahan (BFnrd201853_CR107) 2011; 144 SJ Haggarty (BFnrd201853_CR43) 2003; 10 L Whitesell (BFnrd201853_CR139) 2009; 13 CJ Gerry (BFnrd201853_CR242) 2016; 138 M Cornu (BFnrd201853_CR260) 2013; 23 JJ Badillo (BFnrd201853_CR202) 2011; 52 DL Klayman (BFnrd201853_CR192) 1985; 228 PM Petrone (BFnrd201853_CR238) 2013; 18 SM Gustafsdottir (BFnrd201853_CR240) 2013; 8 DS Tan (BFnrd201853_CR46) 2005; 1 RW Heidebrecht Jr (BFnrd201853_CR204) 2012; 3 D Lee (BFnrd201853_CR39) 1999; 121 G Sliwoski (BFnrd201853_CR14) 2013; 66 J Silhavy (BFnrd201853_CR223) 2010; 2 EA Harrington (BFnrd201853_CR130) 2004; 10 MA Fischbach (BFnrd201853_CR172) 2009; 325 Y Feng (BFnrd201853_CR95) 2014; 24 NK Tonks (BFnrd201853_CR153) 2013; 280 SH Cohen (BFnrd201853_CR210) 2010; 31 J Drews (BFnrd201853_CR226) 2000; 287 E Wandzioch (BFnrd201853_CR158) 2014; 74 |
References_xml | – volume: 56 start-page: 23 year: 2016 ident: BFnrd201853_CR154 publication-title: Annu. Rev. Pharmacol. Toxicol. doi: 10.1146/annurev-pharmtox-010715-103440 – volume: 13 start-page: 132 year: 2011 ident: BFnrd201853_CR98 publication-title: Nat. Cell Biol. doi: 10.1038/ncb2152 – volume: 11 start-page: 481 year: 2011 ident: BFnrd201853_CR146 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3068 – volume: 53 start-page: 261 year: 2009 ident: BFnrd201853_CR212 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01443-07 – volume: 126 start-page: 14095 year: 2004 ident: BFnrd201853_CR103 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja0457415 – volume: 144 start-page: 646 year: 2011 ident: BFnrd201853_CR107 publication-title: Cell doi: 10.1016/j.cell.2011.02.013 – volume: 1830 start-page: 3670 year: 2013 ident: BFnrd201853_CR7 publication-title: Biochim. Biophys. Acta doi: 10.1016/j.bbagen.2013.02.008 – ident: BFnrd201853_CR62 – volume: 2 start-page: 16020 year: 2016 ident: BFnrd201853_CR213 publication-title: Nat. Rev. Dis. Primers doi: 10.1038/nrdp.2016.20 – volume: 11 start-page: 611 year: 2015 ident: BFnrd201853_CR233 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.1858 – volume: 8 start-page: 438 year: 2017 ident: BFnrd201853_CR175 publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.7b00030 – volume: 112 start-page: E4281 year: 2015 ident: BFnrd201853_CR78 publication-title: Proc. Natl Acad. Sci. USA – volume: 4 start-page: 206 year: 2005 ident: BFnrd201853_CR5 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1657 – volume: 23 start-page: 53 year: 2013 ident: BFnrd201853_CR260 publication-title: Curr. Opin. Genet. Dev. doi: 10.1016/j.gde.2012.12.005 – volume: 15 start-page: 605 year: 2016 ident: BFnrd201853_CR12 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd.2016.109 – volume: 228 start-page: 1049 year: 1985 ident: BFnrd201853_CR192 publication-title: Science doi: 10.1126/science.3887571 – volume: 308 start-page: 395 year: 2005 ident: BFnrd201853_CR53 publication-title: Science doi: 10.1126/science.1109755 – volume: 13 start-page: 469 year: 2009 ident: BFnrd201853_CR139 publication-title: Expert Opin. Ther. Targets doi: 10.1517/14728220902832697 – volume: 57 start-page: 8496 year: 2014 ident: BFnrd201853_CR205 publication-title: J. Med. Chem. doi: 10.1021/jm500994n – volume: 8 start-page: e80999 year: 2013 ident: BFnrd201853_CR240 publication-title: PLoS ONE doi: 10.1371/journal.pone.0080999 – volume: 52 start-page: 9576 year: 2013 ident: BFnrd201853_CR82 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201302045 – volume: 53 start-page: 8840 year: 2014 ident: BFnrd201853_CR173 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201310843 – volume: 20 start-page: 713 year: 2013 ident: BFnrd201853_CR127 publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2013.03.020 – volume: 131 start-page: 19 year: 2016 ident: BFnrd201853_CR183 publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2016.03.015 – volume: 46 start-page: 5352 year: 2007 ident: BFnrd201853_CR121 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200700762 – volume: 19 start-page: 114 year: 2016 ident: BFnrd201853_CR176 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2015.12.001 – volume: 18 start-page: 674 year: 2013 ident: BFnrd201853_CR238 publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2013.02.005 – volume: 136 start-page: 17726 year: 2014 ident: BFnrd201853_CR32 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja511232b – volume: 287 start-page: 1964 year: 2000 ident: BFnrd201853_CR33 publication-title: Science doi: 10.1126/science.287.5460.1964 – volume: 40 start-page: 3726 year: 2001 ident: BFnrd201853_CR23 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/1521-3773(20011015)40:20<3726::AID-ANIE3726>3.0.CO;2-D – volume: 3 start-page: 442 year: 2007 ident: BFnrd201853_CR18 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio0807-442 – volume: 425 start-page: 851 year: 2003 ident: BFnrd201853_CR85 publication-title: Nature doi: 10.1038/nature02009 – volume: 14 start-page: 733 year: 2015 ident: BFnrd201853_CR255 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4737 – volume: 125 start-page: 8420 year: 2003 ident: BFnrd201853_CR123 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja0352698 – volume: 34 start-page: 419 year: 2016 ident: BFnrd201853_CR119 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3460 – volume: 126 start-page: 13620 year: 2004 ident: BFnrd201853_CR141 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja044798o – volume: 387 start-page: 1211 year: 2016 ident: BFnrd201853_CR217 publication-title: Lancet doi: 10.1016/S0140-6736(15)00151-8 – volume: 530 start-page: 177 year: 2016 ident: BFnrd201853_CR63 publication-title: Nature doi: 10.1038/nature16549 – volume: 137 start-page: 7929 year: 2015 ident: BFnrd201853_CR92 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.5b04284 – volume: 14 start-page: 621 year: 2012 ident: BFnrd201853_CR215 publication-title: ACS Comb. Sci. doi: 10.1021/co300098v – volume: 18 start-page: 6280 year: 2016 ident: BFnrd201853_CR243 publication-title: Org. Lett. doi: 10.1021/acs.orglett.6b03118 – volume: 17 start-page: 3052 year: 1998 ident: BFnrd201853_CR129 publication-title: EMBO J. doi: 10.1093/emboj/17.11.3052 – volume: 31 start-page: 431 year: 2010 ident: BFnrd201853_CR210 publication-title: Infect. Control Hosp. Epidemiol. doi: 10.1086/651706 – volume: 12 start-page: 380 year: 2010 ident: BFnrd201853_CR148 publication-title: Nat. Cell Biol. doi: 10.1038/ncb2038 – volume: 74 start-page: 4295 year: 2014 ident: BFnrd201853_CR158 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-3130 – volume: 50 start-page: 10800 year: 2011 ident: BFnrd201853_CR34 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201007004 – volume: 56 start-page: 7719 year: 2013 ident: BFnrd201853_CR69 publication-title: J. Med. Chem. doi: 10.1021/jm400362b – volume: 13 start-page: 140 year: 2014 ident: BFnrd201853_CR108 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4204 – volume: 432 start-page: 855 year: 2004 ident: BFnrd201853_CR247 publication-title: Nature doi: 10.1038/nature03193 – volume: 211 start-page: 1097 year: 2015 ident: BFnrd201853_CR174 publication-title: J. Infect. Dis. doi: 10.1093/infdis/jiu565 – volume: 1 start-page: 345 year: 2008 ident: BFnrd201853_CR214 publication-title: Microb. Biotechnol. doi: 10.1111/j.1751-7915.2008.00031.x – volume: 61 start-page: 1013 year: 2001 ident: BFnrd201853_CR51 publication-title: Cancer Res. – volume: 13 start-page: 7264 year: 2007 ident: BFnrd201853_CR113 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-07-2184 – volume: 10 start-page: 2621 year: 2008 ident: BFnrd201853_CR74 publication-title: Org. Lett. doi: 10.1021/ol8004936 – volume: 161 start-page: 1252 year: 2015 ident: BFnrd201853_CR66 publication-title: Cell doi: 10.1016/j.cell.2015.05.023 – volume: 108 start-page: 18378 year: 2011 ident: BFnrd201853_CR136 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1115031108 – volume: 59 start-page: 6629 year: 2016 ident: BFnrd201853_CR237 publication-title: J. Med. Chem. doi: 10.1021/acs.jmedchem.5b01874 – volume: 47 start-page: 7048 year: 2008 ident: BFnrd201853_CR159 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200802439 – volume: 132 start-page: 9259 year: 2010 ident: BFnrd201853_CR22 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja102798t – volume: 310 start-page: 451 year: 2005 ident: BFnrd201853_CR52 publication-title: Science doi: 10.1126/science.1116364 – volume: 79 start-page: 629 year: 2016 ident: BFnrd201853_CR9 publication-title: J. Nat. Prod. doi: 10.1021/acs.jnatprod.5b01055 – volume: 457 start-page: 153 year: 2009 ident: BFnrd201853_CR47 publication-title: Nature doi: 10.1038/457153a – volume: 41 start-page: 856 year: 2001 ident: BFnrd201853_CR227 publication-title: J. Chem. Inf. Comput. Sci. doi: 10.1021/ci000403i – volume: 121 start-page: 10648 year: 1999 ident: BFnrd201853_CR39 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja992658m – volume: 27 start-page: 3691 year: 2012 ident: BFnrd201853_CR261 publication-title: Nephrol. Dial. Transplant. doi: 10.1093/ndt/gfs442 – volume: 1 start-page: 74 year: 2005 ident: BFnrd201853_CR46 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio0705-74 – volume: 8 start-page: 407 year: 2004 ident: BFnrd201853_CR251 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/j.cbpa.2004.04.017 – volume: 107 start-page: 18787 year: 2010 ident: BFnrd201853_CR19 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1012741107 – volume: 52 start-page: 5550 year: 2011 ident: BFnrd201853_CR202 publication-title: Tetrahedron Lett. doi: 10.1016/j.tetlet.2011.08.071 – volume: 5 start-page: 1 year: 2014 ident: BFnrd201853_CR115 publication-title: Nat. Commun. doi: 10.1038/ncomms4155 – volume: 11 start-page: 709 year: 2012 ident: BFnrd201853_CR97 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3802 – volume: 5 start-page: 21 year: 2015 ident: BFnrd201853_CR156 publication-title: Front. Oncol. doi: 10.3389/fonc.2015.00021 – volume: 330 start-page: 257 year: 1994 ident: BFnrd201853_CR211 publication-title: N. Engl. J. Med. doi: 10.1056/NEJM199401273300406 – volume: 19 start-page: 837 year: 2013 ident: BFnrd201853_CR170 publication-title: Nat. Med. doi: 10.1038/nm.3248 – volume: 5 start-page: 5521 year: 2014 ident: BFnrd201853_CR199 publication-title: Nat. Commun. doi: 10.1038/ncomms6521 – volume: 138 start-page: 8920 year: 2016 ident: BFnrd201853_CR242 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.6b04614 – volume: 361 start-page: 455 year: 2009 ident: BFnrd201853_CR193 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa0808859 – volume: 34 start-page: 70 year: 2016 ident: BFnrd201853_CR241 publication-title: Nat. Biotechnol. doi: 10.1038/nbt.3419 – volume: 4 start-page: 842 year: 2003 ident: BFnrd201853_CR128 publication-title: Nat. Rev. Mol. Cell Biol. doi: 10.1038/nrm1245 – volume: 3 start-page: 301 year: 2004 ident: BFnrd201853_CR235 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd1343 – volume: 32 start-page: 478 year: 2015 ident: BFnrd201853_CR21 publication-title: Nat. Prod. Rep. doi: 10.1039/C4NP00104D – volume: 19 start-page: 6319 year: 2009 ident: BFnrd201853_CR90 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2009.09.089 – volume: 1 start-page: 55 year: 1999 ident: BFnrd201853_CR253 publication-title: J. Comb. Chem. doi: 10.1021/cc9800071 – volume: 5 start-page: 262 year: 2004 ident: BFnrd201853_CR110 publication-title: Nat. Rev. Genet. doi: 10.1038/nrg1317 – volume: 4 start-page: e238 year: 2007 ident: BFnrd201853_CR218 publication-title: PLoS Med. doi: 10.1371/journal.pmed.0040238 – volume: 13 start-page: 588 year: 2014 ident: BFnrd201853_CR105 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4366 – volume: 275 start-page: 1943 year: 1997 ident: BFnrd201853_CR152 publication-title: Science. doi: 10.1126/science.275.5308.1943 – volume: 465 start-page: 347 year: 2013 ident: BFnrd201853_CR230 publication-title: Pflügers Arch. doi: 10.1007/s00424-013-1234-z – volume: 3 start-page: 4239 year: 2001 ident: BFnrd201853_CR42 publication-title: Org. Lett. doi: 10.1021/ol016915f – volume: 1 start-page: 1 year: 2010 ident: BFnrd201853_CR102 publication-title: Nat. Commun. – volume: 16 start-page: 531 year: 2017 ident: BFnrd201853_CR68 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd.2017.111 – volume: 49 start-page: 293 year: 2013 ident: BFnrd201853_CR100 publication-title: Oral Oncol. doi: 10.1016/j.oraloncology.2012.11.008 – volume: 19 start-page: 85 year: 2012 ident: BFnrd201853_CR6 publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2011.12.014 – volume: 109 start-page: 107 year: 2015 ident: BFnrd201853_CR188 publication-title: Pathog. Glob. Health doi: 10.1179/2047773215Y.0000000013 – volume: 39 start-page: 3012 year: 2000 ident: BFnrd201853_CR25 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/1521-3773(20000901)39:17<3012::AID-ANIE3012>3.0.CO;2-G – volume: 15 start-page: 3059 year: 2001 ident: BFnrd201853_CR84 publication-title: Genes Dev. doi: 10.1101/gad.938601 – volume: 13 start-page: 227 year: 2013 ident: BFnrd201853_CR195 publication-title: Cell Host Microbe doi: 10.1016/j.chom.2012.12.006 – volume: 371 start-page: 403 year: 2014 ident: BFnrd201853_CR196 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1315860 – volume: 5 start-page: 278 year: 2015 ident: BFnrd201853_CR131 publication-title: Front. Oncol. doi: 10.3389/fonc.2015.00278 – volume: 5 start-page: 1308 year: 2014 ident: BFnrd201853_CR125 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml500388q – volume: 51 start-page: 716 year: 2007 ident: BFnrd201853_CR186 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.01144-06 – volume: 341 start-page: 1238303 year: 2013 ident: BFnrd201853_CR116 publication-title: Science doi: 10.1126/science.1238303 – volume: 13 start-page: 42 year: 2015 ident: BFnrd201853_CR4 publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro3380 – volume: 11 start-page: 900 year: 2012 ident: BFnrd201853_CR246 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3895 – volume: 280 start-page: 346 year: 2013 ident: BFnrd201853_CR153 publication-title: FEBS J. doi: 10.1111/febs.12077 – volume: 121 start-page: 9073 year: 1999 ident: BFnrd201853_CR38 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja992144n – volume: 47 start-page: 48 year: 2008 ident: BFnrd201853_CR35 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200703073 – volume: 6 start-page: 861 year: 2010 ident: BFnrd201853_CR16 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.479 – volume: 383 start-page: 407 year: 1996 ident: BFnrd201853_CR83 publication-title: Nature doi: 10.1038/383407a0 – volume: 8 start-page: 349ps15 year: 2016 ident: BFnrd201853_CR1 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.aaf2608 – volume: 329 start-page: 229 year: 2010 ident: BFnrd201853_CR96 publication-title: Science doi: 10.1126/science.1190354 – volume: 18 start-page: 1014 year: 2013 ident: BFnrd201853_CR229 publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2012.10.011 – volume: 533 start-page: 338 year: 2016 ident: BFnrd201853_CR54 publication-title: Nature doi: 10.1038/nature17967 – volume: 130 start-page: 1005 year: 2007 ident: BFnrd201853_CR137 publication-title: Cell doi: 10.1016/j.cell.2007.07.020 – volume: 7 start-page: 852 year: 2016 ident: BFnrd201853_CR71 publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.6b00230 – volume: 2 start-page: 709 year: 2000 ident: BFnrd201853_CR37 publication-title: Org. Lett. doi: 10.1021/ol005574n – volume: 132 start-page: 16962 year: 2010 ident: BFnrd201853_CR94 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja105119r – volume: 139 start-page: 11300 year: 2017 ident: BFnrd201853_CR207 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.7b06994 – volume: 322 start-page: 881 year: 2008 ident: BFnrd201853_CR56 publication-title: Science doi: 10.1126/science.1156409 – volume: 108 start-page: 6757 year: 2011 ident: BFnrd201853_CR124 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1015251108 – volume: 1 start-page: 47 year: 1997 ident: BFnrd201853_CR15 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/S1367-5931(97)80107-X – volume: 8 start-page: 179 year: 2011 ident: BFnrd201853_CR118 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.758 – volume: 100 start-page: 4389 year: 2003 ident: BFnrd201853_CR44 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0430973100 – volume: 111 start-page: E5455 year: 2014 ident: BFnrd201853_CR200 publication-title: Proc. Natl Acad. Sci. USA – volume: 22 start-page: 76 year: 2015 ident: BFnrd201853_CR180 publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2014.11.012 – ident: BFnrd201853_CR61 doi: 10.1016/S0140-6736(12)62129-1 – volume: 25 start-page: 495 year: 2011 ident: BFnrd201853_CR245 publication-title: J. Comput. Aided Mol. Des. doi: 10.1007/s10822-011-9444-y – volume: 86 start-page: 2 year: 2015 ident: BFnrd201853_CR250 publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/j.addr.2015.01.009 – volume: 14 start-page: 331 year: 2010 ident: BFnrd201853_CR140 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/j.cbpa.2010.03.022 – volume: 13 start-page: 943 year: 2017 ident: BFnrd201853_CR179 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2420 – volume: 7 start-page: 944 year: 2016 ident: BFnrd201853_CR117 publication-title: ACS Med. Chem. Lett. doi: 10.1021/acsmedchemlett.6b00264 – volume: 287 start-page: 26829 year: 2012 ident: BFnrd201853_CR262 publication-title: J. Biol. Chem. doi: 10.1074/jbc.M112.345702 – volume: 93 start-page: 299 year: 2013 ident: BFnrd201853_CR67 publication-title: Clin. Pharmacol. Ther. doi: 10.1038/clpt.2012.236 – volume: 13 start-page: 493 year: 2006 ident: BFnrd201853_CR88 publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2006.03.004 – volume: 20 start-page: 13384 year: 2015 ident: BFnrd201853_CR10 publication-title: Molecules doi: 10.3390/molecules200713384 – volume: 6 start-page: 159 year: 2010 ident: BFnrd201853_CR224 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.296 – volume: 15 start-page: 544 year: 2014 ident: BFnrd201853_CR191 publication-title: Genome Biol. doi: 10.1186/s13059-014-0544-6 – volume: 8 start-page: 255 year: 2004 ident: BFnrd201853_CR228 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/j.cbpa.2004.04.003 – volume: 11 start-page: 849 year: 2013 ident: BFnrd201853_CR187 publication-title: Nat. Rev. Microbiol. doi: 10.1038/nrmicro3138 – volume: 7 start-page: 283ra53 year: 2015 ident: BFnrd201853_CR111 publication-title: Sci. Transl Med. doi: 10.1126/scitranslmed.aaa7161 – volume: 92 start-page: 1725 year: 2002 ident: BFnrd201853_CR135 publication-title: J. Appl. Physiol. doi: 10.1152/japplphysiol.01143.2001 – volume: 14 start-page: 751 year: 2015 ident: BFnrd201853_CR163 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4683 – volume: 287 start-page: 1960 year: 2000 ident: BFnrd201853_CR226 publication-title: Science doi: 10.1126/science.287.5460.1960 – volume: 108 start-page: 6817 year: 2011 ident: BFnrd201853_CR20 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1015024108 – volume: 55 start-page: 558 year: 2012 ident: BFnrd201853_CR144 publication-title: J. Med. Chem. doi: 10.1021/jm201263k – volume: 14 start-page: 1923 year: 2014 ident: BFnrd201853_CR13 publication-title: Curr. Top. Med. Chem. doi: 10.2174/1568026614666140929124445 – volume: 18 start-page: 569 year: 2016 ident: BFnrd201853_CR252 publication-title: ACS Comb. Sci. doi: 10.1021/acscombsci.6b00050 – volume: 11 start-page: 536 year: 2015 ident: BFnrd201853_CR65 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.1867 – volume: 538 start-page: 344 year: 2016 ident: BFnrd201853_CR178 publication-title: Nature doi: 10.1038/nature19804 – ident: BFnrd201853_CR216 – volume: 14 start-page: 759 year: 2017 ident: BFnrd201853_CR258 publication-title: Nat. Methods doi: 10.1038/nmeth.4365 – volume: 45 start-page: 3635 year: 2006 ident: BFnrd201853_CR41 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200600497 – volume: 98 start-page: 8554 year: 2001 ident: BFnrd201853_CR231 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.141230798 – volume: 7 start-page: 1377 year: 2012 ident: BFnrd201853_CR222 publication-title: ACS Chem. Biol. doi: 10.1021/cb300151m – volume: 29 start-page: 5204 year: 2010 ident: BFnrd201853_CR138 publication-title: Oncogene doi: 10.1038/onc.2010.277 – volume: 9 start-page: 195 year: 2013 ident: BFnrd201853_CR64 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.1197 – volume: 56 start-page: 4125 year: 2013 ident: BFnrd201853_CR93 publication-title: J. Med. Chem. doi: 10.1021/jm400397x – volume: 9 start-page: 268 year: 2010 ident: BFnrd201853_CR133 publication-title: Mol. Cancer Ther. doi: 10.1158/1535-7163.MCT-09-0765 – volume: 45 start-page: 2615 year: 2002 ident: BFnrd201853_CR249 publication-title: J. Med. Chem. doi: 10.1021/jm020017n – volume: 49 start-page: 1646 year: 2016 ident: BFnrd201853_CR11 publication-title: Acc. Chem. Res. doi: 10.1021/acs.accounts.6b00185 – volume: 368 start-page: 299 year: 2013 ident: BFnrd201853_CR3 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMp1215093 – volume: 108 start-page: 6745 year: 2011 ident: BFnrd201853_CR30 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1015268108 – volume: 9 start-page: 28 year: 2009 ident: BFnrd201853_CR134 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc2559 – volume: 28 start-page: 1653 year: 2009 ident: BFnrd201853_CR147 publication-title: Oncogene doi: 10.1038/onc.2009.4 – volume: 12 start-page: 672 year: 2016 ident: BFnrd201853_CR149 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2115 – volume: 74 start-page: 417 year: 2010 ident: BFnrd201853_CR165 publication-title: Microbiol. Mol. Biol. Rev. doi: 10.1128/MMBR.00016-10 – volume: 10 start-page: 262 year: 2004 ident: BFnrd201853_CR130 publication-title: Nat. Med doi: 10.1038/nm1003 – volume: 48 start-page: 104 year: 2009 ident: BFnrd201853_CR31 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200804486 – volume: 536 start-page: 285 year: 2016 ident: BFnrd201853_CR55 publication-title: Nature doi: 10.1038/nature19057 – volume: 108 start-page: 6769 year: 2011 ident: BFnrd201853_CR76 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1015254108 – volume: 66 start-page: 334 year: 2013 ident: BFnrd201853_CR14 publication-title: Pharmacol. Rev. doi: 10.1124/pr.112.007336 – volume: 55 start-page: 11139 year: 2016 ident: BFnrd201853_CR28 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201605460 – volume: 56 start-page: 3544 year: 2012 ident: BFnrd201853_CR197 publication-title: Antimicrob. Agents Chemother. doi: 10.1128/AAC.06377-11 – volume: 14 start-page: 357 year: 1996 ident: BFnrd201853_CR86 publication-title: Nat. Genet. doi: 10.1038/ng1196-357 – volume: 43 start-page: 43 year: 2011 ident: BFnrd201853_CR60 publication-title: Nat. Genet. doi: 10.1038/ng.733 – volume: 10 start-page: 413 year: 2015 ident: BFnrd201853_CR198 publication-title: ACS Chem. Biol. doi: 10.1021/cb500616x – volume: 48 start-page: 722 year: 2015 ident: BFnrd201853_CR17 publication-title: Acc. Chem. Res. doi: 10.1021/ar500432k – volume: 432 start-page: 294 year: 2004 ident: BFnrd201853_CR109 publication-title: Nature doi: 10.1038/nature03095 – volume: 10 start-page: 383 year: 2003 ident: BFnrd201853_CR43 publication-title: Chem. Biol. doi: 10.1016/S1074-5521(03)00095-4 – volume: 16 start-page: 395 year: 2015 ident: BFnrd201853_CR132 publication-title: Lancet Oncol. doi: 10.1016/S1470-2045(15)70051-3 – volume: 133 start-page: 154 year: 2008 ident: BFnrd201853_CR157 publication-title: Cell doi: 10.1016/j.cell.2008.02.041 – volume: 9 start-page: 1 year: 2015 ident: BFnrd201853_CR184 publication-title: PLoS Negl. Trop. Dis. doi: 10.1371/journal.pntd.0004094 – volume: 36 start-page: 585 year: 2004 ident: BFnrd201853_CR99 publication-title: Nat. Genet. doi: 10.1038/ng1362 – volume: 325 start-page: 1089 year: 2009 ident: BFnrd201853_CR172 publication-title: Science doi: 10.1126/science.1176667 – volume: 73 start-page: 6548 year: 2013 ident: BFnrd201853_CR155 publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-13-1994 – ident: BFnrd201853_CR59 doi: 10.1038/nature12828 – volume: 2 start-page: 735 year: 2010 ident: BFnrd201853_CR29 publication-title: Nat. Chem. doi: 10.1038/nchem.730 – volume: 102 start-page: 8567 year: 2005 ident: BFnrd201853_CR45 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.0503221102 – volume: 23 start-page: 3 year: 1997 ident: BFnrd201853_CR171 publication-title: Adv. Drug Deliv. Rev. doi: 10.1016/S0169-409X(96)00423-1 – volume: 171 start-page: 1437 year: 2017 ident: BFnrd201853_CR239 publication-title: Cell doi: 10.1016/j.cell.2017.10.049 – volume: 257 start-page: 1050 year: 1992 ident: BFnrd201853_CR162 publication-title: Science doi: 10.1126/science.257.5073.1050 – volume: 2 start-page: 1 year: 2010 ident: BFnrd201853_CR223 publication-title: Cold Spring Harb. Perspect. Biol. doi: 10.1101/cshperspect.a000414 – volume: 17 start-page: 561 year: 2010 ident: BFnrd201853_CR256 publication-title: Chem. Biol. doi: 10.1016/j.chembiol.2010.05.013 – volume: 3 start-page: 349 year: 2017 ident: BFnrd201853_CR185 publication-title: ACS Infect. Dis. doi: 10.1021/acsinfecdis.6b00206 – volume: 134 start-page: 5068 year: 2012 ident: BFnrd201853_CR160 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja300799t – volume: 13 start-page: 714 year: 2013 ident: BFnrd201853_CR2 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc3599 – volume: 513 start-page: 481 year: 2014 ident: BFnrd201853_CR248 publication-title: Nature doi: 10.1038/513481a – volume: 10 start-page: 1 year: 2015 ident: BFnrd201853_CR81 publication-title: PLoS ONE doi: 10.1371/journal.pone.0120295 – volume: 43 start-page: 46 year: 2004 ident: BFnrd201853_CR36 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200300626 – volume: 522 start-page: 315 year: 2015 ident: BFnrd201853_CR209 publication-title: Nature doi: 10.1038/nature14451 – volume: 8 start-page: 358 year: 2012 ident: BFnrd201853_CR27 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.911 – volume: 45 start-page: 1520 year: 2006 ident: BFnrd201853_CR24 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200503132 – volume: 12 start-page: 306 year: 2008 ident: BFnrd201853_CR8 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/j.cbpa.2008.03.016 – volume: 135 start-page: 9675 year: 2013 ident: BFnrd201853_CR72 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja400034k – volume: 17 start-page: 183 year: 2017 ident: BFnrd201853_CR57 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd.2017.226 – volume: 139 start-page: 12559 year: 2017 ident: BFnrd201853_CR89 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.7b06087 – volume: 12 start-page: 581 year: 2013 ident: BFnrd201853_CR58 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4051 – volume: 9 start-page: 21 year: 2012 ident: BFnrd201853_CR26 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.1130 – volume: 12 start-page: 1004 year: 2016 ident: BFnrd201853_CR167 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.2207 – volume: 3 start-page: 112 year: 2012 ident: BFnrd201853_CR204 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml200244k – volume: 18 start-page: 1067 year: 2013 ident: BFnrd201853_CR70 publication-title: Drug Discov. Today doi: 10.1016/j.drudis.2013.07.001 – volume: 55 start-page: 3479 year: 2012 ident: BFnrd201853_CR208 publication-title: J. Med. Chem. doi: 10.1021/jm3001373 – volume: 7 start-page: 13196 year: 2016 ident: BFnrd201853_CR80 publication-title: Nat. Commun. doi: 10.1038/ncomms13196 – volume: 21 start-page: 505 year: 2015 ident: BFnrd201853_CR91 publication-title: Clin. Cancer Res. doi: 10.1158/1078-0432.CCR-14-0507 – volume: 13 start-page: 828 year: 2014 ident: BFnrd201853_CR112 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd4389 – volume: 85 start-page: 59 year: 2010 ident: BFnrd201853_CR169 publication-title: Antiviral Res. doi: 10.1016/j.antiviral.2009.10.003 – volume: 2 start-page: 698 year: 2011 ident: BFnrd201853_CR73 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml200120m – volume: 57 start-page: 276 year: 2003 ident: BFnrd201853_CR104 publication-title: Chimia doi: 10.2533/000942903777679253 – volume: 14 start-page: 89 year: 2012 ident: BFnrd201853_CR101 publication-title: ACS Comb. Sci. doi: 10.1021/co200161z – ident: BFnrd201853_CR201 – volume: 5 start-page: 149 year: 2014 ident: BFnrd201853_CR181 publication-title: ACS Med. Chem. Lett. doi: 10.1021/ml400403u – volume: 111 start-page: 10911 year: 2014 ident: BFnrd201853_CR225 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1410933111 – volume: 5 start-page: 876 year: 2005 ident: BFnrd201853_CR106 publication-title: Nat. Rev. Cancer doi: 10.1038/nrc1736 – volume: 42 start-page: 864 year: 2003 ident: BFnrd201853_CR234 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200390233 – volume: 294 start-page: 1343 year: 2001 ident: BFnrd201853_CR151 publication-title: Science doi: 10.1126/science.1065817 – volume: 12 start-page: 371 year: 2013 ident: BFnrd201853_CR164 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd3975 – volume: 113 start-page: 1084 year: 2004 ident: BFnrd201853_CR190 publication-title: J. Clin. Invest. doi: 10.1172/JCI21682 – volume: 7 start-page: 47 year: 2005 ident: BFnrd201853_CR40 publication-title: Org. Lett. doi: 10.1021/ol047945w – volume: 108 start-page: 6811 year: 2011 ident: BFnrd201853_CR120 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1015248108 – volume: 14 start-page: 362 year: 2010 ident: BFnrd201853_CR49 publication-title: Curr. Opin. Chem. Biol. doi: 10.1016/j.cbpa.2010.03.018 – volume: 114 start-page: 3162 year: 1992 ident: BFnrd201853_CR50 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja00034a086 – volume: 33 start-page: 668 year: 2016 ident: BFnrd201853_CR166 publication-title: Nat. Prod. Rep. doi: 10.1039/C5NP00127G – volume: 24 start-page: 24 year: 2014 ident: BFnrd201853_CR95 publication-title: Cell Res. doi: 10.1038/cr.2013.168 – volume: 77 start-page: 7187 year: 2012 ident: BFnrd201853_CR206 publication-title: J. Org. Chem. doi: 10.1021/jo300974j – volume: 11 start-page: 296 year: 2016 ident: BFnrd201853_CR236 publication-title: ACS Chem. Biol. doi: 10.1021/acschembio.5b00981 – volume: 47 start-page: 4891 year: 2004 ident: BFnrd201853_CR244 publication-title: J. Med. Chem. doi: 10.1021/jm049740z – volume: 329 start-page: 1175 year: 2010 ident: BFnrd201853_CR177 publication-title: Science doi: 10.1126/science.1193225 – volume: 6 start-page: 29 year: 2007 ident: BFnrd201853_CR168 publication-title: Nat. Rev. Drug Discov. doi: 10.1038/nrd2201 – volume: 116 start-page: 9683 year: 2016 ident: BFnrd201853_CR145 publication-title: Chem. Rev. doi: 10.1021/acs.chemrev.5b00760 – volume: 108 start-page: 6699 year: 2011 ident: BFnrd201853_CR48 publication-title: Proc. Natl Acad. Sci. USA doi: 10.1073/pnas.1103205108 – volume: 54 start-page: 6217 year: 2015 ident: BFnrd201853_CR126 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201501394 – volume: 347 start-page: 385 year: 2002 ident: BFnrd201853_CR161 publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa013552 – volume: 5 start-page: 154 year: 2009 ident: BFnrd201853_CR77 publication-title: Nat. Chem. Biol. doi: 10.1038/nchembio.142 – volume: 78 start-page: 1 year: 1996 ident: BFnrd201853_CR194 publication-title: Mol. Biochem. Parasitol. doi: 10.1016/S0166-6851(96)02593-5 – volume: 25 start-page: 2100 year: 2015 ident: BFnrd201853_CR79 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2015.03.073 – volume: 38 start-page: 261 year: 2016 ident: BFnrd201853_CR221 publication-title: Semin. Immunopathol. doi: 10.1007/s00281-015-0522-4 – volume: 1835 start-page: 76 year: 2013 ident: BFnrd201853_CR114 publication-title: Biochim. Biophys. Acta – volume: 21 start-page: 2601 year: 2011 ident: BFnrd201853_CR122 publication-title: Bioorg. Med. Chem. Lett. doi: 10.1016/j.bmcl.2011.01.134 – volume: 137 start-page: 5563 year: 2015 ident: BFnrd201853_CR75 publication-title: J. Am. Chem. Soc. doi: 10.1021/jacs.5b02150 – volume: 47 start-page: 2808 year: 2008 ident: BFnrd201853_CR182 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.200705415 – volume: 519 start-page: 154 year: 2012 ident: BFnrd201853_CR219 publication-title: Arch. Biochem. Biophys. doi: 10.1016/j.abb.2012.01.016 – volume: 128 start-page: 7754 year: 2006 ident: BFnrd201853_CR143 publication-title: J. Am. Chem. Soc. doi: 10.1021/ja062621j – volume: 5 start-page: 1843 year: 2014 ident: BFnrd201853_CR150 publication-title: Med. Chem. Commun. doi: 10.1039/C4MD00237G – volume: 23 start-page: 10 year: 2016 ident: BFnrd201853_CR254 publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2015.11.011 – volume: 348 start-page: 1376 year: 2015 ident: BFnrd201853_CR232 publication-title: Science doi: 10.1126/science.aab1433 – volume: 6 start-page: 44 year: 2010 ident: BFnrd201853_CR87 publication-title: Mol. Biosyst. doi: 10.1039/B910196A – volume: 153 start-page: 293 year: 2013 ident: BFnrd201853_CR220 publication-title: Cell doi: 10.1016/j.cell.2013.03.034 – ident: BFnrd201853_CR189 doi: 10.1016/S0140-6736(03)15162-8 – volume: 25 start-page: 194 year: 2017 ident: BFnrd201853_CR259 publication-title: Cell Chem. Biol. doi: 10.1016/j.chembiol.2017.11.004 – volume: 32 start-page: 9 year: 2017 ident: BFnrd201853_CR257 publication-title: Cancer Cell doi: 10.1016/j.ccell.2017.06.005 – volume: 49 start-page: 6533 year: 2010 ident: BFnrd201853_CR142 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201003212 – volume: 54 start-page: 10958 year: 2015 ident: BFnrd201853_CR203 publication-title: Angew. Chem. Int. Ed. Engl. doi: 10.1002/anie.201505717 |
SSID | ssj0016172 |
Score | 2.6268215 |
SecondaryResourceType | review_article |
Snippet | Strategies such as diversity-oriented synthesis aim to explore novel areas of chemical space efficiently by populating small-molecule screening libraries with... Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for... Screening of small-molecule libraries is a productive method for identifying both chemical probes of disease-related targets and potential starting points for... |
SourceID | pubmedcentral proquest pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 333 |
SubjectTerms | 631/154/1435 631/154/309 631/92/613 Biomedicine Biotechnology Cancer Research Libraries Medicinal Chemistry Molecular Medicine Pharmacology/Toxicology review-article |
Title | Chemical probes and drug leads from advances in synthetic planning and methodology |
URI | https://link.springer.com/article/10.1038/nrd.2018.53 https://www.ncbi.nlm.nih.gov/pubmed/29651105 https://www.proquest.com/docview/2040742310 https://www.proquest.com/docview/3143092683 https://www.proquest.com/docview/2025312979 https://pubmed.ncbi.nlm.nih.gov/PMC6707071 |
Volume | 17 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1La9wwEB7a5NJLSd9u0qBCmkOJW9uy9TiVtiSEQsMSEtibsSW5DQTtdr172H_fGVv2ss3SqzUaJI80-qSRvgE4yYUxSvEm1pWg06rUxrqu87hB6F_XleEypffOP6_E5W3-Y1pMw4FbG65VDj6xc9R2ZuiMHDfpOW3jEI18mf-JKWsURVdDCo3HsJ8iEqHUDXI6brgIunfRzlzmcSqlCO_zEq4--wXRhKbqU8G3V6QHMPPhbcl_QqbdSnRxAE8DhGRfe5s_g0fOP4fTSc9BvT5jN5snVe0ZO2WTDTv1-gVcDxQBjHLJuJZV3jK7WP1i92jultF7ExZuBrTszrN27REkojI2DwmOuip96ulO6Uu4vTi_-X4Zh8QKsSkSvowFGo7zOtNJYqxsMptR8DBLNEUJbVpIqR03CPXyumlkgx8TZxpjE1mpmleSv4I9P_PuDTD0GMpZxACFKXInuaokaUTfZZSrhIzg4_BzSxNYxyn5xX3ZRb-5KtESJVmiLHgEJ6PwvCfb2C12NFipDDOuLTfjY2cxR1yY6EworP1-LMapRPGRyrvZilRk6JEyLXUEr3ubj83ItEBomhQRyK3RMAoQTfd2ib_73dF1C0mUSmkEH4Zxs2nWjt69_X_vDuEJCfZ3Lo9gb7lYuXeIi5b1cTf4j2H_2_nV5PovviwO6A |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-N7gFeEN9kDDDStge0QGInsfMwIT42dWyrqqmT9hYSx2GTprQ0rVD_Of427hInVVnF215j-xTnzpeffb7fAewEkdZKicKN04hOq_zcjbMscAuE_lmWaiF9ync-G0T9i-D7ZXi5AX_aXBi6Vtn6xNpR52NNZ-S4SQ9oG4do5NPkl0tVoyi62pbQSG1phfygphiziR0nZvEbt3DVwfE31Pcu50eHo69911YZcHXoiZkb4SyEyHjseTqXBc85RdI47vRVqHI_lDI2QiPuCbKikAU-9IwudO7JVGUilQLl3oPNgA5QerD55XAwPO_iGIQP6vwmGbi-lJHNEPSE-lhOiajUVx9CsfpPvAV0b9_X_CdoW_8Ljx7BQwti2efG6h7DhimfwN6wYcFe7LPRMqmr2md7bLjkx148hfOWpIBRNRtTsbTMWT6d_2Q3aHAVo4wXZu8mVOy6ZNWiRJiKwtjElliqhzTFr2uhz-DiTj76c-iV49K8BIY-S5kcUUiow8BIoVJJEtF7amXSSDrwvv24iba851R-4yap4-9CJaiJhDSRhMKBna7zpKH7WN9tu9VSYtd8lSwtdG2zQGTqxTxSOPpd14yLmSI0aWnGcxLB0SfyWMYOvGh03r0GjyMEx17ogFyxhq4DEYWvtpTXVzVheCSJ1Ml3YLe1m-VrrZnd1v9n9xbu90dnp8np8eDkFTygQc0N0G3ozaZz8xpR2ix7Y5cCgx93vfr-Ah6GUEw |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwEB6VIiEuiDcpBYzU9oAamtiO7RwQQpRVS6FaoVbaW5o4Dq1UZZfNrtD-NX4dM3mtlq649RrbozjzyDee8QzAjlTWGiMKP04VnVaFuR9nmfQLhP5ZllqhQ7rv_P1UHZ3Lr6NotAF_urswlFbZ2cTaUOdjS2fk6KRLcuMQjRwUbVrE8HDwcfLLpw5SFGnt2mk0InLiFr_Rfas-HB8ir3c5H3w5-3zktx0GfBsFYuYr3IEQGY-DwOa64DmnKBpHL99EJg8jrWMnLGIemRWFLvBh4Gxh80CnJhOpFkj3DtzVQkpqG6FHvbNHbkMdaZVa-qHWqr0bGAhzUE6pRGlo3kdi9W94A-LezNT8J1xb_wUHD-FBC1_Zp0beHsGGKx_D3rCpf73YZ2fL61zVPttjw2Vl7MUT-NGVJ2DUx8ZVLC1zlk_nP9k1ilrF6K4La7MSKnZVsmpRIkBFYmzSNleqlzRtr2uiT-H8Vj75M9gsx6V7AQytlXE54o_IRtJpYVJNFNFuWuNSpT14133cxLYVz6nxxnVSR96FSZATCXEiiYQHO_3kSVPoY_207Y5LSavtVbKUzbXDAjFpEHNlcPXbfhjVmGIzaenGcyLB0RryWMcePG943r8GjxXC4iDyQK9IQz-BSoSvjpRXl3WpcKWpnFPowW4nN8vXWrO7rf_v7g3cQ51Lvh2fnryE-7SmSf3chs3ZdO5eITybZa9rPWBwcduK9xfzXE3o |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Chemical+probes+and+drug+leads+from+advances+in+synthetic+planning+and+methodology&rft.jtitle=Nature+reviews.+Drug+discovery&rft.au=Gerry%2C+Christopher+J&rft.au=Schreiber%2C+Stuart+L&rft.date=2018-05-01&rft.eissn=1474-1784&rft.volume=17&rft.issue=5&rft.spage=333&rft_id=info:doi/10.1038%2Fnrd.2018.53&rft_id=info%3Apmid%2F29651105&rft.externalDocID=29651105 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1474-1776&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1474-1776&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1474-1776&client=summon |